Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 262
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
Ann Dermatol Venereol ; 145(10): 623-632, 2018 Oct.
Artigo em Francês | MEDLINE | ID: mdl-30143320

RESUMO

Dermatomycoses are dermatological infections very commonly encountered in private dermatological practice since they affect up to one third of the population. However, the symptoms are very often shared by other skin infections and disorders and may be highly atypical. It is thus impossible to make a diagnosis with any certainty on clinical grounds alone. For this reason, mycological diagnosis is essential to either confirm or rule out dermatomycosis, and is unavoidable when antifungal therapy is required for the treatment of ringworm of the scalp or beard, or for onychomycosis. It is also vital where therapy guided by the clinical appearance of lesions has failed or in the event of recurring skin lesions. Confirmation of mycosis enables antifungals to be initiated and a negative test warrants investigation for other underlying causes for the lesions seen. However, regardless of the mycological diagnostic technique employed, the quality of the results depends chiefly on the quality of sampling of the infected site, but also on the expertise of the microbiologist. Standard mycological testing remains the most informative, the least expensive and the sole examination capable of isolating the causative fungus irrespective of the type of mycosis, such as dermatophytosis, scytalidiosis, mould-induced ungual infection, candidiasis, or infections due to Malassezia sp. This is the only examination able to identify epidemiological variations. All other more recent techniques are either based upon simple demonstration of the fungal elements involved, without identification of the fungal species in question, or else they are reliant upon a fungal database that is generally highly incomplete.


Assuntos
Dermatomicoses/diagnóstico , Micologia/métodos , Antifúngicos/uso terapêutico , Dermatomicoses/tratamento farmacológico , Dermatomicoses/microbiologia , Dermatomicoses/patologia , Dermoscopia/métodos , Fungos/isolamento & purificação , Humanos , Técnicas de Tipagem Micológica , Onicomicose/diagnóstico , Onicomicose/microbiologia , Onicomicose/patologia , Exame Físico , Couro Cabeludo/microbiologia , Couro Cabeludo/patologia , Manejo de Espécimes/métodos , Coloração e Rotulagem/métodos
2.
Ann Dermatol Venereol ; 144(6-7): 438-442, 2017.
Artigo em Francês | MEDLINE | ID: mdl-28396061

RESUMO

BACKGROUND: Chromomycosis, or chromoblastomycosis, is caused by cutaneous inoculation of dematiaceous fungi of telluric or plant origin. It is generally seen in tropical or subtropical zones. Treatment of the condition is known to be complex. Herein we report a case of chromomycosis contracted in a temperate region of Eastern Europe/Central Asia that was effectively treated with oral itraconazole and terbinafine in combination with cryotherapy. PATIENTS AND METHODS: A 44-year-old immunocompetent male subject consulted for a lesion on the buttocks that he had sustained 16 years earlier, and which, although never previously treated, had only become troublesome within the last few months. The examination revealed a large erythemato-squamous plaque containing a heterogeneous infiltrate. The diagnosis was based upon biopsy, with histological examination revealing sooty mould ; culture of a second sample showed the causative agent to be Fonsecaea pedrosoi. After 30 months of treatment combining oral terbinafine at a very high dose (1000mg/day), topical terbinafine and adjuvant cryotherapy, considerable, though incomplete, improvement was obtained. Finally, combined use of terbinafine (500mg/day) and itraconazole (200mg/day) led to clinical and histological cure. DISCUSSION: The possibility of acquiring chromomycosis other than in a tropical zone is slight but has nevertheless been described, particularly in Eastern Europe. In our patient, the exact source of contamination is unknown, although it may have been acquired through frequent horse-riding or use of saunas. This case confirms the efficacy of combined itraconazole and terbinafine against this condition, which is usually difficult to treat.


Assuntos
Antifúngicos/uso terapêutico , Cromoblastomicose/diagnóstico , Cromoblastomicose/tratamento farmacológico , Itraconazol/uso terapêutico , Naftalenos/uso terapêutico , Adulto , Ascomicetos/isolamento & purificação , Biópsia , Nádegas/patologia , Cromoblastomicose/microbiologia , Crioterapia/métodos , Quimioterapia Combinada , Europa Oriental , Humanos , Masculino , Terbinafina , Resultado do Tratamento
3.
Horm Metab Res ; 46(6): 390-6, 2014 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-24806747

RESUMO

Our aim was to characterize the effects and the underlying mechanisms of the lipid-regulating agent Niaspan(®) on both insulin action and triglyceride decrease in 20 nondiabetic, dyslipidemic men with metabolic syndrome receiving Niaspan(®) (2 g/day) or placebo for 8 weeks in a randomized, cross-over study. The effects on plasma lipid profile were characterized at the beginning and the end of each treatment period; insulin sensitivity was assessed using the 2-step euglycemic hyperinsulinemic clamp and VLDL-triglyceride turnover by measuring plasma glycerol enrichment, both at the end of each treatment period. The mechanism of action of nicotinic acid was studied in HuH7 and mouse primary hepatocytes. Lipid profile was improved after Niaspan(®) treatment with a significant-28% decrease in triglyceride levels, a+17% increase in HDL-C concentration and unchanged levels of fasting nonesterified fatty acid. VLDL-tri-glyceride production rate was markedly reduced after Niaspan(®) (-68%). However, the treatment induced hepatic insulin resistance, as assessed by reduced inhibition of endogenous glucose production by insulin (0.7±0.4 vs. 1.0±0.5 mg/kg · min, p<0.05) and decrease in fasting hepatic insulin sensitivity index (4.8±1.8 vs. 3.2±1.6, p<0.05) in the Niaspan(®) condition. Nicotinic acid also reduced insulin action in HuH7 and primary hepatocytes, independently of the activation of hepatic PKCε. This effect was associated with an increase in diacylglycerol and a decrease in tri-glyceride contents that occurred in the absence of modification of DGAT2 expression and activity. Eight weeks of Niaspan(®) treatment in dyslipidemic patients with metabolic syndrome induce hepatic insulin resistance. The mechanism could involve an accumulation of diacylglycerol and an alteration of insulin signaling in hepatocytes.


Assuntos
Insulina/farmacologia , Metabolismo dos Lipídeos/efeitos dos fármacos , Fígado/metabolismo , Niacina/farmacologia , Animais , Linhagem Celular Tumoral , Diglicerídeos/metabolismo , Hepatócitos/efeitos dos fármacos , Hepatócitos/metabolismo , Humanos , Cinética , Lipoproteínas VLDL/metabolismo , Masculino , Camundongos , Pessoa de Meia-Idade , Niacina/administração & dosagem , Proteína Quinase C/antagonistas & inibidores , Proteína Quinase C/metabolismo , Inibidores de Proteínas Quinases/farmacologia , Transdução de Sinais/efeitos dos fármacos , Triglicerídeos/metabolismo
4.
Anaesthesia ; 69(1): 46-52, 2014 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-24320856

RESUMO

Ketamine and pregabalin each provide postoperative analgesia, although the combination has yet to be evaluated. One hundred and forty-two patients undergoing total hip arthroplasty were randomly assigned to receive ketamine alone, pregabalin alone, ketamine and pregabalin combined, or placebo. Pain scores at rest and on movement, morphine consumption, side-effects, pressure pain thresholds and secondary hyperalgesia were evaluated. Mean (SD) total 48-h morphine use was reduced in patients given ketamine alone (52 (22) mg) and pregabalin alone (44 (20) mg) compared with placebo (77 (36) mg) p < 0.001. Morphine use was further reduced in patients given both ketamine and pregabalin (38 (19) mg) with an interaction between ketamine and pregabalin (ANOVA factorial; p = 0.028). Secondary hyperalgesia was reduced by ketamine. There were no differences between groups in pain scores after surgery, pressure pain thresholds or side-effects. The combination of pregabalin and ketamine has a small, beneficial clinical effect.


Assuntos
Analgésicos/administração & dosagem , Artroplastia de Quadril , Ketamina/administração & dosagem , Dor Pós-Operatória/prevenção & controle , Ácido gama-Aminobutírico/análogos & derivados , Administração Oral , Adulto , Idoso , Analgesia Controlada pelo Paciente , Analgésicos/efeitos adversos , Analgésicos Opioides/administração & dosagem , Método Duplo-Cego , Esquema de Medicação , Quimioterapia Combinada , Feminino , Humanos , Infusões Intravenosas , Ketamina/efeitos adversos , Masculino , Pessoa de Meia-Idade , Morfina/administração & dosagem , Movimento , Medição da Dor/métodos , Assistência Perioperatória/métodos , Pregabalina , Estudos Prospectivos , Resultado do Tratamento , Ácido gama-Aminobutírico/administração & dosagem , Ácido gama-Aminobutírico/efeitos adversos
5.
Cell Rep ; 42(7): 112730, 2023 07 25.
Artigo em Inglês | MEDLINE | ID: mdl-37453057

RESUMO

Cancer-associated mesothelial cells (CAMCs) in the tumor microenvironment are thought to promote growth and immune evasion. We find that, in mouse and human ovarian tumors, cancer cells express anti-Müllerian hormone (AMH) while CAMCs express its receptor AMHR2, suggesting a paracrine axis. Factors secreted by cancer cells induce AMHR2 expression during their reprogramming into CAMCs in mouse and human in vitro models. Overexpression of AMHR2 in the Met5a mesothelial cell line is sufficient to induce expression of immunosuppressive cytokines and growth factors that stimulate ovarian cancer cell growth in an AMH-dependent way. Finally, syngeneic cancer cells implanted in transgenic mice with Amhr2-/- CAMCs grow significantly slower than in wild-type hosts. The cytokine profile of Amhr2-/- tumor-bearing mice is altered and their tumors express less immune checkpoint markers programmed-cell-death 1 (PD1) and cytotoxic T lymphocyte-associated protein 4 (CTLA4). Taken together, these data suggest that the AMH/AMHR2 axis plays a critical role in regulating the pro-tumoral function of CAMCs in ovarian cancer.


Assuntos
Neoplasias Ovarianas , Hormônios Peptídicos , Feminino , Humanos , Animais , Camundongos , Hormônio Antimülleriano/genética , Neoplasias Ovarianas/genética , Camundongos Transgênicos , Receptores de Fatores de Crescimento Transformadores beta/metabolismo , Microambiente Tumoral
6.
J Eur Acad Dermatol Venereol ; 26(7): 875-8, 2012 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-21838827

RESUMO

BACKGROUND: Shoes worn with bare feet function as a fungal reservoir and lead to persistent dermatophytosis. OBJECTIVE: This study was designed to evaluate two formulations of terbinafine (1% spray powder or solution) to treat the insoles of shoes colonized by skin scales infected with Trichophyton rubrum and to determine the contact time necessary to achieve decontamination. METHODS: Infected skin scales weighing 0.5 g, taken from the feet of patients with confirmed T. rubrum infection, was dispersed onto insoles pre-moistened with sterile saline solution (to mimic perspiration). Three types of insole were tested (felt, latex, leather). After inoculation, insoles were placed separately in new cardboard boxes at ambient temperature, and re-humidified with sterile normal saline solution for 48 h before being treated; untreated insoles served as controls. Scales were scraped off at 48 h or 96 h, and dropped into tubes of Sabouraud agar, incubated at 27°C and examined at 3 and 6 weeks. RESULTS: Cultures from all control insoles showed numerous T. rubrum colonies. In contrast, cultures from all insoles treated with a single application of terbinafine 1% spray solution or powder, and taken after 48 h or 96 h contact with the product, remained sterile at 3 weeks and 6 weeks. CONCLUSION: This study demonstrated the successful treatment of insoles colonized by T. rubrum-infected skin scales. Terbinafine 1% spray solution and powder showed good efficacy; the dermatophyte could no longer be cultured 48 h after a single application of terbinafine.


Assuntos
Antifúngicos/farmacologia , Naftalenos/farmacologia , Sapatos , Tinha/prevenção & controle , Trichophyton/efeitos dos fármacos , Antifúngicos/administração & dosagem , Antifúngicos/uso terapêutico , Humanos , Naftalenos/administração & dosagem , Naftalenos/uso terapêutico , Pós , Soluções , Terbinafina , Trichophyton/isolamento & purificação
7.
Ann Occup Hyg ; 55(2): 152-63, 2011 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-21177264

RESUMO

OBJECTIVES: The association between workplace bullying and psychotropic drug use is not well established. This study was aimed at exploring the association between workplace bullying, and its characteristics, and psychotropic drug use and studying the mediating role of physical and mental health. METHODS: The study population consisted of a random sample of 3132 men and 4562 women of the working population in the south-east of France. Workplace bullying, evaluated using the validated instrument elaborated by Leymann, and psychotropic drug use, as well as covariates, were measured using a self-administered questionnaire. Covariates included age, marital status, presence of children, education, occupation, working hours, night work, physico-chemical exposures at work, self-reported health, and depressive symptoms. Statistical analysis was performed using logistic regression analysis and was carried out separately for men and women. RESULTS: Workplace bullying was strongly associated with psychotropic drug use. Past exposure to bullying increased the risk for this use. The more frequent and the longer the exposure to bullying, the stronger the association with psychotropic drug use. Observing bullying on someone else at the workplace was associated with psychotropic drug use. Adjustment for covariates did not modify the results. Additional adjustment for self-reported health and depressive symptoms reduced the magnitude of the associations, especially for men. CONCLUSIONS: The association between bullying and psychotropic drug use was found to be significant and strong and was partially mediated by physical and mental health.


Assuntos
Bullying , Nível de Saúde , Transtornos Mentais , Psicotrópicos , Transtornos Relacionados ao Uso de Substâncias/epidemiologia , Local de Trabalho , Adulto , Bullying/psicologia , Estudos Transversais , Feminino , França/epidemiologia , Humanos , Masculino , Transtornos Mentais/epidemiologia , Pessoa de Meia-Idade , Prevalência , Fatores de Risco , Transtornos Relacionados ao Uso de Substâncias/psicologia , Inquéritos e Questionários
8.
Sci Rep ; 11(1): 8712, 2021 04 22.
Artigo em Inglês | MEDLINE | ID: mdl-33888788

RESUMO

Obesity is associated with both chronic and acute respiratory illnesses, such as asthma, chronic obstructive pulmonary disease (COPD) or increased susceptibility to infectious diseases. Anatomical but also systemic and local metabolic alterations are proposed contributors to the pathophysiology of lung diseases in the context of obesity. To bring perspective to this discussion, we used NMR to compare the obesity-associated metabolomic profiles of the lung with those of the liver, heart, skeletal muscles, kidneys, brain and serum from male C57Bl/6J mice fed with a high-fat and high-sucrose (HFHSD) diet vs. standard (SD) chow for 14 weeks. Our results showed that the lung was the second most affected organ after the liver, and that the two organs shared reduced one-carbon (1C) metabolism and increased lipid accumulation. Altered 1C metabolism was found in all organs and in the serum, but serine levels were increased only in the lung of HFHSD compared to SD. Lastly, tricarboxylic acid (TCA)-derived metabolites were specifically and oppositely regulated in the serum and kidneys but not in other organs. Collectively, our data highlighted that HFHSD induced specific metabolic changes in all organs, the lung being the second most affected organ, the main alterations affecting metabolite concentrations of the 1C pathway and, to a minor extend, TCA. The absolute metabolite quantification performed in this study reveals some metabolic specificities affecting both the liver and the lung, that may reveal common metabolic determinants to the ongoing pathological process.


Assuntos
Dieta Hiperlipídica , Sacarose Alimentar/administração & dosagem , Metabolismo dos Lipídeos , Fígado/metabolismo , Pulmão/metabolismo , Obesidade/metabolismo , Animais , Espectroscopia de Ressonância Magnética , Masculino , Camundongos , Camundongos Endogâmicos BALB C
9.
Diagn Interv Imaging ; 101(9): 507-517, 2020 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-32094095

RESUMO

Magnetic resonance imaging (MRI) has become the reference imaging for the management of a large number of diseases. The number of MR examinations increases every year, simultaneously with the number of patients receiving a cardiac electronic implantable device (CEID). A CEID was considered an absolute contraindication for MRI for years. The progressive replacement of conventional pacemakers and defibrillators by MR-conditional CEIDs and recent data on the safety of MRI in patients with "MR-nonconditional" CEIDs have progressively increased the demand for MRI in patients with a CEID. However, some risks are associated with MRI in CEID carriers, even with "MR-conditional" devices because these devices are not "MR-safe". A specific programing of the device in "MR-mode" and monitoring patients during MRI remain mandatory for all patients with a CEID. A standardized patient workflow based on an institutional protocol should be established in each institution performing such examinations. This joint position paper of the Working Group of Pacing and Electrophysiology of the French Society of Cardiology and the Société française d'imagerie cardiaque et vasculaire diagnostique et interventionnelle (SFICV) describes the effect and risks associated with MRI in CEID carriers. We propose recommendations for patient workflow and monitoring and CEID programming in MR-conditional, "MR-conditional nonguaranteed" and MR-nonconditional devices.


Assuntos
Cardiologia , Desfibriladores Implantáveis , Marca-Passo Artificial , Eletrônica , Humanos , Imageamento por Ressonância Magnética
10.
Sleep ; 32(9): 1211-9, 2009 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-19750926

RESUMO

STUDY OBJECTIVES: The purpose of this study was to explore the associations between workplace bullying, the characteristics of workplace bullying, and sleep disturbances in a large sample of employees of the French working population. DESIGN: Workplace bullying, evaluated using the validated instrument developed by Leymann, and sleep disturbances, as well as covariates, were measured using a self-administered questionnaire. Covariates included age, marital status, presence of children, education, occupation, working hours, night work, physical and chemical exposures at work, self-reported health, and depressive symptoms. Statistical analysis was performed using logistic regression analysis and was carried out separately for men and women. SETTING: General working population. PARTICIPANTS: The study population consisted of a random sample of 3132 men and 4562 women of the working population in the southeast of France. RESULTS: Workplace bullying was strongly associated with sleep disturbances. Past exposure to bullying also increased the risk for this outcome. The more frequent the exposure to bullying, the higher the risk of experiencing sleep disturbances. Observing someone else being bullied in the workplace was also associated with the outcome. Adjustment for covariates did not modify the results. Additional adjustment for self-reported health and depressive symptoms diminished the magnitude of the associations that remained significant. CONCLUSIONS: The prevalence of workplace bullying (around 10%) was found to be high in this study as well was the impact of this major job-related stressor on sleep disturbances. Although no conclusion about causality could be drawn from this cross-sectional study, the findings suggest that the contribution of workplace bullying to the burden of sleep disturbances may be substantial.


Assuntos
Agressão/psicologia , Dominação-Subordinação , Doenças Profissionais/epidemiologia , Doenças Profissionais/psicologia , Transtornos do Sono-Vigília/epidemiologia , Transtornos do Sono-Vigília/psicologia , Estresse Psicológico/epidemiologia , Adulto , Distribuição por Idade , Causalidade , Comorbidade , Conflito Psicológico , Estudos Transversais , Feminino , França/epidemiologia , Humanos , Masculino , Pessoa de Meia-Idade , Razão de Chances , Prevalência , Distribuição por Sexo , Estresse Psicológico/psicologia , Inquéritos e Questionários , Local de Trabalho/psicologia , Local de Trabalho/estatística & dados numéricos
11.
Clin Exp Allergy ; 38(5): 767-73, 2008 May.
Artigo em Inglês | MEDLINE | ID: mdl-18325032

RESUMO

BACKGROUND: Early wheezing in infants is a potential risk factor for persistence of asthma into adulthood. Moreover, a personal or familial history of atopy are risk factors associated with persistence of pre-existing wheezing during childhood. However, their relative importance remains unclear. OBJECTIVES: Firstly to determine the critical thresholds of common biological markers of atopy in wheezy infants associated with persistence of wheezing into childhood and secondly to rank these biological markers together with clinical parameters according to the strength of their association with wheezing persistence. METHODS: A cohort of infants less than 30 months old with recurrent wheezing was established in order to assess severity of respiratory symptoms and to look for the presence of atopy. At the age of 6 years, they were re-evaluated regarding remission of wheezing over the previous 12-months period. RESULTS: Data were available for 219 subjects. In 27% of them, wheezing persisted at 6 years of age. Critical biological thresholds associated with the risk of wheezing persistence were: (1) a blood eosinophilia count >or=470/mm(3) (defining eosinophilia), and (2) a total serum IgE level >or=45 IU/mL (defining elevated IgE) during infancy. A multiple component factorial analysis identified a dimension associating eosinophilia, elevated IgE and allergic sensitization on the one hand with persistent wheezing at 6 years of age on the other (lambda=0.15). According to a segmentation analysis, the main discriminative parameter of wheezing persistence was eosinophilia. Thus a lack of eosinophilia alone could account for 91% of infants in remission, and when combined with absence of allergic sensitization, remission was correctly discriminated in 96.9% of the study population. CONCLUSION: Our data strongly suggest that the lack of eosinophilia in wheezy infants without ongoing infection could predict future remission of wheezing in a large majority of cases.


Assuntos
Eosinofilia , Sons Respiratórios/diagnóstico , Sons Respiratórios/fisiopatologia , Criança , Pré-Escolar , Estudos de Coortes , Feminino , Humanos , Hipersensibilidade Imediata/fisiopatologia , Lactente , Recém-Nascido , Masculino , Valor Preditivo dos Testes , Fatores de Risco , Índice de Gravidade de Doença
12.
Ann Dermatol Venereol ; 135(8-9): 561-6, 2008.
Artigo em Francês | MEDLINE | ID: mdl-18789289

RESUMO

BACKGROUND: Increasing prevalence of onychomycosis has been observed in recent years and regular epidemiological studies of the disease are thus necessary. In addition, treatment of onychomycosis by private dermatologists needs to be better understood. This study was carried out to improve knowledge about the epidemiology of onychomycosis and its management in private practice in France. PATIENTS AND METHODS: Four hundred and eighty-five private dermatologists practising throughout France took part in the study. Between September 2001 and December 2002, they collected the following data for each patient with clinically diagnosed onychomycosis: age, gender, concomitant diseases, regular practice of sport, clinical type of onychomycosis, mycological sampling and results, treatment type, monotherapy or combined therapy. RESULTS: Forty-seven percent of patients (i.e. 1826) underwent mycological sampling. In 1200 cases, a fungus was identified. The results for these 1200 patients were as follows: 44% of patients had matrix involvement. Associated diseases were: diabetes (5%), psoriasis (4.5%), immunosuppression (1%) and peripheral vasculopathy (5%). Onychomycosis involved the toes in 88.7% of cases, the fingers in 8.7% and both toes and nails in 2.6%. In the toes, the clinical diagnosis was subungual distal onychomycosis in 74.2% of cases, superficial leuconychia in 11.1%, proximal subungual onychomycosis in 3.3%, and total onychomycodystrophy in 11.4%. In the toes, a dermatophyte was isolated in 84% of cases, yeast in 8% and a mould in 6%. In the fingers, a dermatophyte was isolated in 37% of cases, yeast in 55% and a mould in 8%. Monotherapy was prescribed to 35% of patients and combined therapy in 65%. Oral treatment represented 59% of monotherapies. DISCUSSION: The main results of our study are that dermatologists do not perform any mycological sampling before treating onychomycosis in 53% of cases; in 56% of cases, onychomycosis does not involve the nail matrix; onychomycosis is localized in the toes 10 times more often than in the fingers; the distal subungual clinical form represents more than 70% of cases, in fingers and toes; in the toes, the total onychomycodystrophy clinical form represents 11.4% of cases; dermatologists prescribe monotherapy in 35% of cases, with 59% of these monotherapies comprising an oral treatment, while matrix involvement is present in only 44% of cases. CONCLUSION: Continual medical education efforts must be continued concerning onychomycosis diagnosis and management in accordance with the French Dermatological Society recommendations.


Assuntos
Dermatologia/tendências , Dermatoses do Pé , Dermatoses da Mão , Onicomicose , Adolescente , Adulto , Antifúngicos/uso terapêutico , Arthrodermataceae/isolamento & purificação , Coleta de Dados , Complicações do Diabetes , Feminino , Dermatoses do Pé/diagnóstico , Dermatoses do Pé/tratamento farmacológico , Dermatoses do Pé/epidemiologia , Dermatoses do Pé/microbiologia , França/epidemiologia , Dermatoses da Mão/diagnóstico , Dermatoses da Mão/tratamento farmacológico , Dermatoses da Mão/epidemiologia , Dermatoses da Mão/microbiologia , Humanos , Masculino , Prontuários Médicos , Pessoa de Meia-Idade , Onicomicose/complicações , Onicomicose/diagnóstico , Onicomicose/tratamento farmacológico , Onicomicose/epidemiologia , Onicomicose/microbiologia , Prevalência , Prática Privada , Psoríase/complicações , Adulto Jovem
13.
Sci Rep ; 8(1): 7975, 2018 May 17.
Artigo em Inglês | MEDLINE | ID: mdl-29773826

RESUMO

A correction to this article has been published and is linked from the HTML and PDF versions of this paper. The error has not been fixed in the paper.

15.
Br J Anaesth ; 99(6): 794-800, 2007 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-17928302

RESUMO

BACKGROUND: Blood transfusion strategies should reduce both blood transfusion and costs. Possible solutions include autologous donation for selected patients and the prescription of erythropoietin (EPO). METHODS: We conducted a quality improvement program to examine the effect of a transfusion strategy algorithm in primary knee (TKA) and hip arthroplasty (THA). Our algorithm is presented as a diagram and is based on tolerated and expected blood losses. Patient characteristics, blood loss, transfusions given, autologous blood wastage, and costs were examined during an initial evaluation and after implementation of the algorithm. RESULTS: Analysis of 302 (initial evaluation) and 173 (post-implementation) arthroplasties demonstrated a 55% reduction in the prescription of autologous blood donation. The proportion of EPO prescriptions increased from 6.6% to 17.3% (P<0.05). There was a 56% overall reduction in transfusions to fewer autologous (32% vs 12%, P<0.0001) and allogeneic transfusions (21% vs 13%, NS). There were 50% fewer wasted autologous blood units (P=0.002) and a 50% reduction in hospital costs (euro345 vs 169) with no significant change in overall costs (euro439 vs 407). Anaesthetists applied the algorithm in 97% of patients, and it is still in use 1 yr after evaluation. CONCLUSIONS: In this study, the implementation of an algorithm for transfusion strategy changed practice and improved quality of care. The costs for EPO, its administration, and monitoring outside hospital were offset by the reduction in hospital transfusion costs.


Assuntos
Artroplastia de Quadril , Artroplastia do Joelho , Transfusão de Sangue/estatística & dados numéricos , Custos Hospitalares/estatística & dados numéricos , Idoso , Idoso de 80 Anos ou mais , Algoritmos , Artroplastia de Quadril/economia , Artroplastia do Joelho/economia , Perda Sanguínea Cirúrgica/prevenção & controle , Transfusão de Sangue/economia , Transfusão de Sangue/métodos , Transfusão de Sangue Autóloga/economia , Transfusão de Sangue Autóloga/estatística & dados numéricos , Custos de Medicamentos/estatística & dados numéricos , Eritropoetina/economia , Eritropoetina/uso terapêutico , Feminino , França , Custos de Cuidados de Saúde/estatística & dados numéricos , Humanos , Masculino , Pessoa de Meia-Idade , Qualidade da Assistência à Saúde , Proteínas Recombinantes
16.
Arch Mal Coeur Vaiss ; 100 Spec No 1: 85-8, 2007 Jan.
Artigo em Francês | MEDLINE | ID: mdl-17405570

RESUMO

In the field of cardiac pacing, the past year has not been marked by the publication of decisive scientific works, but several important publications have continued to witness the dynamism of this discipline. Selecting the significant facts in 2006 was not easy. Yet, in the following lines, we have integrated them in the dynamic of this speciality. The validation of the concept of resynchronization is now definitively accepted, and its actual place in the strategy of treatment of heart failure is clearer. With the issue of the systematic adjunction of an anti-tachycardia function, we reach the meeting point between cardiac pacing, arrhythmology and heart failure.


Assuntos
Estimulação Cardíaca Artificial/tendências , Cardiologia/tendências , Frequência Cardíaca , Humanos , Reprodutibilidade dos Testes , Taquicardia/fisiopatologia , Resultado do Tratamento
17.
Ann Cardiol Angeiol (Paris) ; 56(1): 21-9, 2007 Jan.
Artigo em Francês | MEDLINE | ID: mdl-17343035

RESUMO

UNLABELLED: Although antiplatelet therapy with ASA-clopidogrel reduces the risk of cardiovascular episodes after PCI, a substantial number of events occur during follow-up. Sustained platelet reactivity under dual antiplatelet therapy was recently associated with increased risk of recurrent atherothrombotic events after PCI. Whereas it appears significant to determine clopidogrel responsiveness, the accurate platelet function assay is still under investigation. OBJECTIVES: (i) to determine the proportion of "low-responders" or "resistants" patients during coronary syndrome (ii) to identify determinants of interindividual variability response to clopidogrel (iii) to compare aggregometry and VASP phosphorylation measured by flow cytometry. Patients were treated by clopidogrel (300 mg loading dose and 75 mg maintenance dose) and ASA (160 mg) (N=27). Additional treatment by GPIIbIIIa antagonists was given to high-risk patients (N=9). Platelet function was monitored by ADP aggregometry (5, 10, 20 microM) and VASP phosphorylation before any treatment by clopidogrel (d0) and at least five days after (d5). The platelet reactivity index (PRI), expressed as percentage, is the difference in VASP fluorescence intensity between resting (+ PGE1) and activated (ADP) platelets. At d5, low responsiveness to clopidogrel was defined by either (i) a PRI > 67.3% corresponding to the mean value -2SD measured in untreated patients (dO) (ii) or an absolute change (delta d0-d5) in aggregation (ADP 10 microM) < to 30%. RESULTS: PRI, platelet aggregometry to ADP was significantly reduced following clopidogrel treatment (P < 0.01). A wide inter-individual variability to clopidogrel was observed at d5 (PRI from 11 to 83%). Whatever the platelet function used, a large proportion of patients were detected as "low-responders" (37% by VASP, 44% by ADP aggregometry). Absolute change in ADP aggregation was correlated to the variation of PRI (R = 0.559; P = 0.02). Contrary to ADP aggregometry, PRI was not influenced by GPIIbIIIa antagonists or prior administration of ASA. However, the conformity of the two methods to evaluate clopidogrel responsiveness was only 66%. No differences in platelet aggregometry could be observed at d5 between "low" and "good-responders" defined by VASP analysis. At d5, a higher PRI value could be detected in male and patients with history of dyslipemia. CONCLUSION: During coronary syndrome, impaired platelet responsiveness to clopidogrel was observed in a large proportion of patients whatever the platelet function assay used. VASP analysis was found insensitive to GPIIbIIIa or aspirin administration. Possible mechanisms linking clopidogrel "resistance" measured by VASP assay and enhanced thrombogenicity remain to be characterized. Indeed, clopidogrel "resistance" defined by VASP analysis was not associated with higher platelet aggregation.


Assuntos
Difosfato de Adenosina/farmacologia , Plaquetas/efeitos dos fármacos , Proteínas Sanguíneas/metabolismo , Moléculas de Adesão Celular/metabolismo , Proteínas dos Microfilamentos/metabolismo , Infarto do Miocárdio/terapia , Fosfoproteínas/metabolismo , Inibidores da Agregação Plaquetária/uso terapêutico , Agregação Plaquetária/efeitos dos fármacos , Ticlopidina/análogos & derivados , Idoso , Aspirina/uso terapêutico , Clopidogrel , Resistência a Medicamentos , Feminino , Citometria de Fluxo , Fluoresceína-5-Isotiocianato , Corantes Fluorescentes , Seguimentos , Humanos , Masculino , Infarto do Miocárdio/sangue , Fosforilação/efeitos dos fármacos , Complexo Glicoproteico GPIIb-IIIa de Plaquetas/antagonistas & inibidores , Síndrome , Ticlopidina/uso terapêutico
18.
Ann Dermatol Venereol ; 134(11): 823-8, 2007 Nov.
Artigo em Francês | MEDLINE | ID: mdl-18033060

RESUMO

BACKGROUND: Malassezia folliculitis is most often described in patients living in hot and humid countries or in immunocompromised patients. Its frequency in France is unknown. We report 26 cases diagnosed at Saint-Louis Hospital between May 2002 and April 2004. The clinical features, the contributing factors, the results of direct mycological examination and/or histology and the efficacy of antifungal treatments were compared to the literature. PATIENTS AND METHODS: The inclusion criteria were the presence of folliculitis on the trunk confirmed by direct microscopy and/or histopathology showing abundant yeast cells in the follicles. RESULTS: Patients comprised 22 men and 4 women (M/F sex ratio: 5: 5) with a mean age of 46 years. Five patients (19%) were immunocompromised. In normal patients, the duration of folliculitis was long with a mean of 61 months. The eruption was typical, with follicular papules and superficial pustules distributed predominantly on the trunk. Itching was frequent (70%). Direct microscopy was more often positive than histology (89% vs 33%). Some sixty-five percent of the patients had been previously treated by topical or systemic antibiotics or anti-acne drugs, which was ineffective in all cases. Cure with topical ketoconazole, oral ketoconazole alone or in combination with topical ketoconazole occurred respectively in 12%, 75% and 75% of patients, but with consistent recurrence within 3 to 4 months after cessation of treatment. DISCUSSION: Malassezia folliculitis is probably misdiagnosed, as suggested by the long time between onset and diagnosis and the high frequency of non-antifungal treatments prescribed. In our study, direct mycological examination provided more effective diagnosis than histology. Treatment is difficult especially because of the high frequency of relapses. CONCLUSION: A diagnosis of Malassezia folliculitis should be considered in young adults or immunocompromised patients with an itching follicular eruption. Further therapeutic trials are needed due to the frequency of relapse.


Assuntos
Dermatomicoses/epidemiologia , Foliculite/epidemiologia , Malassezia/isolamento & purificação , Administração Cutânea , Administração Oral , Adolescente , Adulto , Idoso , Antifúngicos/administração & dosagem , Antifúngicos/uso terapêutico , Feminino , Foliculite/microbiologia , França/epidemiologia , Humanos , Hospedeiro Imunocomprometido , Cetoconazol/administração & dosagem , Cetoconazol/uso terapêutico , Masculino , Pessoa de Meia-Idade , Prurido/microbiologia , Recidiva , Estudos Retrospectivos , Fatores de Tempo
19.
Sci Rep ; 7(1): 7816, 2017 08 10.
Artigo em Inglês | MEDLINE | ID: mdl-28798398

RESUMO

Strong magnetic fields, synchrotron emission, and Compton scattering are omnipresent in compact celestial X-ray sources. Emissions in the X-ray energy band are consequently expected to be linearly polarized. X-ray polarimetry provides a unique diagnostic to study the location and fundamental mechanisms behind emission processes. The polarization of emissions from a bright celestial X-ray source, the Crab, is reported here for the first time in the hard X-ray band (~20-160 keV). The Crab is a complex system consisting of a central pulsar, a diffuse pulsar wind nebula, as well as structures in the inner nebula including a jet and torus. Measurements are made by a purpose-built and calibrated polarimeter, PoGO+. The polarization vector is found to be aligned with the spin axis of the pulsar for a polarization fraction, PF = (20.9 ± 5.0)%. This is higher than that of the optical diffuse nebula, implying a more compact emission site, though not as compact as, e.g., the synchrotron knot. Contrary to measurements at higher energies, no significant temporal evolution of phase-integrated polarisation parameters is observed. The polarization parameters for the pulsar itself are measured for the first time in the X-ray energy band and are consistent with observations at optical wavelengths.

20.
Arch Mal Coeur Vaiss ; 99 Spec No 1(1): 79-84, 2006 Jan.
Artigo em Francês | MEDLINE | ID: mdl-16479968

RESUMO

In 2005, the main subject of interest in the field of pacing was cardiac resynchronisation. The results of CARE-HF (Cardiac Resynchronisation on Morbidity and Mortality in Heart Failure), a large multicentre trial, were published. The investigators set out to establish whether resynchronisation pacing had a favourable effect on morbidity and mortality in patients with advanced cardiac failure and desynchronised compared with an identical population treated medically. The results showed that resynchronisation decreased the interventricular desynchronisation, decreased mitral regurgitation and, above all, improved symptoms and quality of life with a reduction in the incidence of complications and the risk of death. This publication is too recent for evaluation of the eventual repercussions of these results on the implantation of resynchronising pacemakers in France. The indication recommended by the scientific societies is still based on criteria which do not take echocardiographic data into account. However, the recommendations will probably change in the near future when the conclusions of trials currently under way, are published. From the technical point of view, the advances in cardiac pacing were mainly the new algorithms which avoid inappropriate ventricular stimulation of dual chamber pacemakers. It is well known that patients implanted with dual chamber pacemakers may, despite optimal adjustment of pacing parameters, have ineffective ventricular stimulation as the impulse falls in the phase of spontaneous ventricular depolarisation or effective but absolutely valueless. Several manufactures now propose pacemakers with algorithms which "search" for ventriculogrammes in order to avoid these situations of inadequate stimulation. Their efficacy has been demonstrated. Finally, in 2005, the diffusion of defibrillators equipped with a resynchronisation function has been confirmed. The conclusions of the COMPANION trial have been influential in promoting this usage although the results are mainly observed abroad.


Assuntos
Estimulação Cardíaca Artificial , Insuficiência Cardíaca/terapia , Desfibriladores , Humanos , Marca-Passo Artificial , Editoração/tendências
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA